Viemed Healthcare (NASDAQ:VMD) posts earnings results

Viemed Healthcare (NASDAQ:VMD – Get Your Free Report ) posted its quarterly earnings results on Wednesday. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.03), Zacks reports. Viemed Healthcare had a return on equity of 9.32% and a net margin of 5.32%. The company had revenue of $54.97 million for the quarter. Viemed Healthcare updated its Q3 2024 EPS guidance.

Viemed Healthcare stock performance

VMD traded up $0.08 during trading on Friday, hitting $7.26. The stock had a trading volume of 67,440 shares compared to its average volume of 152,366. The firm has a market cap of $281.84 million, a PE ratio of 27.92 and a beta of 1.47. The company has a current ratio of 1.28, a quick ratio of 1.14, and a debt-to-equity ratio of 0.05. Viemed Healthcare has a 12-month low of $5.90 and a 12-month high of $10.44. The company has a 50-day simple moving average of $6.89 and a 200-day simple moving average of $7.84.

Analyst upgrades and downgrades

Separately, Lake Street Capital raised Viemed Healthcare to a “strong-buy” rating in a research report on Tuesday, May 7th.

Read our latest analysis on VMD

Viemed Healthcare company profile

(Get a free report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. Provides respiratory disease management solutions, including chronic obstructive pulmonary disease (COPD) treatment, which include non-invasive ventilation, percussion vests and other therapies; and invasive and non-invasive ventilation and related equipment and materials for patients suffering from COPD.

Read more

Receive news and reviews for Viemed Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Viemed Healthcare and related companies with MarketBeat.com ‘s FREE daily email newsletter.